102 related articles for article (PubMed ID: 15618365)
1. Can we monitor cell therapy with MR imaging at clinical field strength after systemic injection?
Clément O
Radiology; 2005 Jan; 234(1):3. PubMed ID: 15618365
[No Abstract] [Full Text] [Related]
2. Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment.
Daldrup-Link HE; Rudelius M; Piontek G; Metz S; Bräuer R; Debus G; Corot C; Schlegel J; Link TM; Peschel C; Rummeny EJ; Oostendorp RA
Radiology; 2005 Jan; 234(1):197-205. PubMed ID: 15618382
[TBL] [Abstract][Full Text] [Related]
3. Targeting of hematopoietic progenitor cells with MR contrast agents.
Daldrup-Link HE; Rudelius M; Oostendorp RA; Settles M; Piontek G; Metz S; Rosenbrock H; Keller U; Heinzmann U; Rummeny EJ; Schlegel J; Link TM
Radiology; 2003 Sep; 228(3):760-7. PubMed ID: 12881578
[TBL] [Abstract][Full Text] [Related]
4. Pitfalls in employing superparamagnetic iron oxide particles for stem cell labelling and in vivo MRI tracking.
Wang YX; Wang HH; Au DW; Zou BS; Teng LS
Br J Radiol; 2008 Dec; 81(972):987-8. PubMed ID: 19029055
[No Abstract] [Full Text] [Related]
5. Comparison of iron oxide labeling properties of hematopoietic progenitor cells from umbilical cord blood and from peripheral blood for subsequent in vivo tracking in a xenotransplant mouse model XXX.
Daldrup-Link HE; Rudelius M; Oostendorp RA; Jacobs VR; Simon GH; Gooding C; Rummeny EJ
Acad Radiol; 2005 Apr; 12(4):502-10. PubMed ID: 15831425
[TBL] [Abstract][Full Text] [Related]
6. Liver. II: Iron oxide-based reticuloendothelial contrast agents for MR imaging. Clinical review.
Petersein J; Saini S; Weissleder R
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):53-60. PubMed ID: 8673716
[TBL] [Abstract][Full Text] [Related]
7. In vivo tracking of superparamagnetic iron oxide nanoparticle-labeled mesenchymal stem cell tropism to malignant gliomas using magnetic resonance imaging. Laboratory investigation.
Wu X; Hu J; Zhou L; Mao Y; Yang B; Gao L; Xie R; Xu F; Zhang D; Liu J; Zhu J
J Neurosurg; 2008 Feb; 108(2):320-9. PubMed ID: 18240929
[TBL] [Abstract][Full Text] [Related]
8. Tracking stem cells in the cardiovascular system.
Chemaly ER; Yoneyama R; Frangioni JV; Hajjar RJ
Trends Cardiovasc Med; 2005 Nov; 15(8):297-302. PubMed ID: 16297767
[TBL] [Abstract][Full Text] [Related]
9. Imaging of rheumatoid arthritis: can MR imaging be used to monitor cellular response of disease?
Mosher TJ
Radiology; 2004 Oct; 233(1):1-2. PubMed ID: 15454613
[No Abstract] [Full Text] [Related]
10. Lymphotrophic nanoparticle enhanced MR imaging (LNMRI) for lymph node imaging.
Saokar A; Braschi M; Harisinghani M
Abdom Imaging; 2006; 31(6):660-7. PubMed ID: 16680506
[TBL] [Abstract][Full Text] [Related]
11. Can MR imaging be used to track delivery of intravascularly administered stem cells?
Mahmood U
Radiology; 2004 Dec; 233(3):625-6. PubMed ID: 15564396
[No Abstract] [Full Text] [Related]
12. How can superparamagnetic iron oxides be used to monitor disease and treatment?
Unger EC
Radiology; 2003 Dec; 229(3):615-6. PubMed ID: 14657295
[No Abstract] [Full Text] [Related]
13. Will ferumoxides-enhanced MR imaging replace CT during arterial portography in the detection of hepatic metastases? Prologue to a promising future.
Soyer P
Radiology; 1996 Sep; 200(3):610-1. PubMed ID: 8756902
[No Abstract] [Full Text] [Related]
14. Real enhancement or merely increased contrast?
Chen JH
AJR Am J Roentgenol; 1997 Jan; 168(1):279-80. PubMed ID: 8976963
[No Abstract] [Full Text] [Related]
15. [Focal nodular hyperplasia of the liver: imaging findings with emphasis on the findings of superparamagnetic iron oxide-enhanced MR imaging].
Han JK; Kim SH
Korean J Hepatol; 2006 Mar; 12(1):116-9. PubMed ID: 16565614
[No Abstract] [Full Text] [Related]
16. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
Montie JE
J Urol; 2005 Sep; 174(3):870-1. PubMed ID: 16093977
[No Abstract] [Full Text] [Related]
17. Sensitive physiologic imaging with contrast-enhanced magnetic resonance imaging.
Litt L
Anesthesiology; 1998 Apr; 88(4):847-50. PubMed ID: 9579490
[No Abstract] [Full Text] [Related]
18. [The characterization value of feridex-enhanced MR imaging for focal hepatic lesions in reference to their histological pathology].
Yang HF; Zhou XP; Yu JQ; Song B; Guang YS; Zhang HY; Chen X
Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):548-50. PubMed ID: 16042902
[No Abstract] [Full Text] [Related]
19. Splenosis: superparamagnetic iron oxide-enhanced MR imaging.
Storm BL; Abbitt PL; Allen DA; Ros PR
AJR Am J Roentgenol; 1992 Aug; 159(2):333-5. PubMed ID: 1632350
[No Abstract] [Full Text] [Related]
20. Functional and anatomic imaging of tumor vasculature: high-resolution MR spectroscopic imaging combined with a superparamagnetic contrast agent.
Karczmar GS; Fan X; Al-Hallaq H; River JN; Tarlo K; Kellar KE; Zamora M; Rinker-Schaeffer C; Lipton MJ
Acad Radiol; 2002 May; 9 Suppl 1():S115-8. PubMed ID: 12019844
[No Abstract] [Full Text] [Related]
[Next] [New Search]
